Research in Organ Transplantation

The research we perform at the Ohio State Comprehensive Transplant Center covers basic, translational and clinical, with the goal of developing the next generation of surgical innovation.

What we learn at the bench, we apply to the bedside.

From Our Experts
Request video transcript

Research Opportunities in the Division of Transplantation Surgery at Ohio State
Request video transcript

Study Finds Immune Cell That Predicts Risk of Organ Rejection In Transplant Patients
Request video transcript

Ex Vivo Lung Perfusion Clinical Trial

Read more

Active clinical trials

Kidney Transplant

Liver Transplant

Lung Transplant

Multi Organ Transplants

Islet Transplant

Infectious Disease

Active Research Grants

Active and pending grants

  • Ginny Bumgardner MD, PhD – NIH T32 grant - Advancing Research Training in Immunology for Surgery Trainees (ARTIST), National Institutes of Health, (NIH, NIAID), 8/1/2014–7/31/2029, $2,326,965
  • Ginny Bumgardner MD, PhD – NIH R01 grant - Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection, (NIH, NIAID) 7/1/2019–6/30/2024, $2,686,090
  • Ginny Bumgardner MD, PhD – NIH T32 grant - Medical Scientist Training Program, The Ohio State University, (NIH, NIGMS), 7/1/2021–6/30/2026, $4,189,808
  • Ginny Bumgardner MD, PhD – NIH T32 grant - Predoctoral Research Training in Clinical and Translational Science, The Ohio State University, (NIH, NCATS) 10/2023–10/2028, $1,500,000
  • Ginny Bumgardner MD, PhD – NIH R38 grant - OSU Stimulating Access to Research in Residency, (NIH, NIAID) 7/1/2024–6/30/2029, $2,063,065
  • Ginny Bumgardner MD, PhD – Doris Duke Charitable Foundation grant, Physician Scientist Retention in Research, 10/15/2021–10/14/2023, $550,000
  • Ginny Bumgardner MD, PhD – NIH T35 grant - Short-term Research in Immunology and Virology Experience (STRIVE), National Institutes of Health, (NIH, NIAID), 5/1/2025–4/30/2030, $525,850
  • Bryan Whitson, MD, PhD – NIH NHLBI R01 grant - Investigating an Artificial Blood Substitute HBOC to Support Extended Duration Ex Vivo Lung Perfusion, 7/15/2025–4/30/2029, $784,227
  • Austin Schenk, MD, PhD – R01, Impact of ableism and state laws designated to mitigate ableism on organ transplant equity for kidney transplant candidates with intellectual or development disabilities, 8/1/2024–6/30/2029, $2,535,815

Research